The civic record
Read. Follow. Verify.Utah SB 113 extends Schedule V prescription validity to two years and amends controlled substance licensing rules
Last action · March 6, 2026: Senate/ filedSponsor: Kirk Cullimore
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
This bill allows prescriptions for Schedule V controlled substances to remain valid for up to two years instead of one year. The measure also modifies licensing, recordkeeping, and prescription requirements for practitioners and pharmacies in Utah, taking effect on May 6, 2026.
Patients requiring long-term Schedule V medications can obtain refills for up to 24 months without needing a new prescription issued by their practitioner.
- Utah regulates controlled substances and practitioner licensing under Title 58 of the Utah Code. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
patients prescribed Schedule V controlled substances
Patients can maintain Schedule V prescriptions for up to two years without obtaining a new prescription from their practitioner.
licensed prescribing practitioners
Practitioners are subject to updated prescription validity timelines and database consultation mandates when issuing high-risk prescriptions.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
How long are Schedule V prescriptions valid under this bill?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in Senate committee.
Procedural history
15 actions- Mar 6, 2026SenateSenate/ filed
- Mar 6, 2026SenateSenate/ strike enacting clause
- Mar 3, 2026SenateSenate/ comm rpt/ sent to Rules
- Mar 2, 2026SenateSenate Comm - Recommends Returned to Rules
- Jan 26, 2026SenateSenate Comm - Not Considered
- Jan 21, 2026SenateCommitteeSenate/ to standing committee
Show 9 earlier actions
- Jan 21, 2026SenateSenate/ received fiscal note from Fiscal Analyst
- Jan 21, 2026ReleasedLFA/ fiscal note publicly available for SB0113
- Jan 20, 2026SenateIntroducedSenate/ 1st reading (Introduced)
- Jan 16, 2026Version SponsorLFA/ fiscal note sent to sponsor for SB0113
- Jan 13, 2026SenateSenate/ received bill from Legislative Research
- Jan 8, 2026Legislative Fiscal AgencyLFA/ bill sent to agencies for fiscal input for SB0113
- Jan 8, 2026Legislative Fiscal AnalystLFA/ bill assigned to staff for fiscal analysis for SB0113
- Jan 8, 2026Legislative Research and General CounselNumbered Bill Publicly Distributed
- Jan 8, 2026Legislative Research and General CounselBill Numbered but not Distributed
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Extension of Schedule V Prescription Duration
Utah extends the expiration window for Schedule V controlled substance prescriptions from one year to two years.
Connected Entities
Sources
le.utah.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 45)
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools